Planning

Concession for Printing and Marketing of the British Pharmacopoeia

MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY

This public procurement record has 1 release in its history.

Planning

20 Dec 2021 at 16:18

Planned Procurement Notice
Summary of the contracting process

The Medicines and Healthcare Products Regulatory Agency is initiating a procurement process for the "Concession for Printing and Marketing of the British Pharmacopoeia." This opportunity falls under the publishing services industry and is located in London, England, with the procurement currently in the planning stage. The tender is set to be published in late January 2022, with an award anticipated in April 2022. The contract duration will span from September 2022 to August 2027, allowing for effective implementation and preparation for the 2024 publication of the British Pharmacopoeia.

This tender presents significant growth opportunities for businesses specialising in publishing, marketing, and digital service delivery. Companies with capabilities in printing, distribution, and e-commerce, particularly those experienced in working with public sector clients, would be well-suited to compete for this contract. Furthermore, potential suppliers are encouraged to engage in a supplier event on 18th January 2022, providing a chance to learn about the requirements and expectations directly from the contracting authority.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Concession for Printing and Marketing of the British Pharmacopoeia

Notice Description

The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. It is produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, in accordance with regulation 317(1) of the Human Medicines Regulations 2012 and makes an important contribution to public health by setting publicly available standards for the quality of medicines. The BP is published annually with three in-year updates, currently in both hardcopy and electronic formats; the latter being available as a download product as well as an online publication accessed via a single-user license or a multi-user license arrangement. The Agency requires the appointment of a service provider to be responsible for all Publishing activities as well as Printing, Distribution, Marketing and Selling of the BP and BAN publications. A core part of the requirement is the provision and maintenance of a website, which operates as a portal to access the electronic formats of the BP, a source of added value material and a sales platform for the BP chemical reference standards, orders for which are fulfilled by the Agency. The link to the current website is https://www.pharmacopoeia.com/, and this web address is owned by the Agency. The Agency expects to publish this tender late January 2022 for the award of a concession contract to one service provider to provide these services as a concessionaire; collaborations with other organisations to bring together the range of expertise (sub-contracting arrangements) would be acceptable, with the service provider ensuring effective and seamless delivery. The appointed concessionaire shall retain the revenue from the service/sales as its fees minus the payment of agreed royalty share to the Agency. The concessionaire shall have exclusivity on the sales of the BP and BAN during the term of the contract. Pricing strategies shall be reviewed and agreed by both parties. This contracting approach is the same as the current set-up and the Agency will share some of its historic sales data and trends at its supplier event and in the tender documentation. We expect to award the contract in April 2022 and agree a contract with mobilisation in September 2022 to facilitate sufficient lead time for implementation and the publication of the BP 2024 in August 2023. We will be holding a supplier engagement event on 18th January 2022 13.30 - 15.30 via a MS Teams video conference to discuss with potential suppliers the requirement and service expectations, and further considerations for the future contract. We will also allow time for questions and answers. If interested in attending or if you have a question you would specifically like to be addressed in session, please email purchasing@mhra.gov.uk with your details (quoting BP Event).

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-ff612bb2-13f0-4bfe-8985-a0efbc33e8f5
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/7a9d993f-e99c-49ff-af29-1a717884f575
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planned Procurement Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Not Specified
Procurement Method Details
Other -
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79970000 - Publishing services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
20 Dec 20214 years ago
Submission Deadline
Not specified
Future Notice Date
24 Jan 2022Expired
Award Date
Not specified
Contract Period
31 Aug 2022 - 31 Aug 2027 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY
Contact Name
Alison Finn
Contact Email
alison.finn@nibsc.org
Contact Phone
07770234628

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-ff612bb2-13f0-4bfe-8985-a0efbc33e8f5-2021-12-20T16:18:58Z",
    "date": "2021-12-20T16:18:58Z",
    "ocid": "ocds-b5fd17-ff612bb2-13f0-4bfe-8985-a0efbc33e8f5",
    "language": "en",
    "initiationType": "tender",
    "planning": {
        "documents": [
            {
                "id": "1",
                "documentType": "plannedProcurementNotice",
                "description": "Future opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/7a9d993f-e99c-49ff-af29-1a717884f575",
                "datePublished": "2021-12-20T16:18:58Z",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "tender": {
        "id": "CF-0539500D0O000000rwimUAA1",
        "title": "Concession for Printing and Marketing of the British Pharmacopoeia",
        "description": "The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. It is produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare Products Regulatory Agency, in accordance with regulation 317(1) of the Human Medicines Regulations 2012 and makes an important contribution to public health by setting publicly available standards for the quality of medicines. The BP is published annually with three in-year updates, currently in both hardcopy and electronic formats; the latter being available as a download product as well as an online publication accessed via a single-user license or a multi-user license arrangement. The Agency requires the appointment of a service provider to be responsible for all Publishing activities as well as Printing, Distribution, Marketing and Selling of the BP and BAN publications. A core part of the requirement is the provision and maintenance of a website, which operates as a portal to access the electronic formats of the BP, a source of added value material and a sales platform for the BP chemical reference standards, orders for which are fulfilled by the Agency. The link to the current website is https://www.pharmacopoeia.com/, and this web address is owned by the Agency. The Agency expects to publish this tender late January 2022 for the award of a concession contract to one service provider to provide these services as a concessionaire; collaborations with other organisations to bring together the range of expertise (sub-contracting arrangements) would be acceptable, with the service provider ensuring effective and seamless delivery. The appointed concessionaire shall retain the revenue from the service/sales as its fees minus the payment of agreed royalty share to the Agency. The concessionaire shall have exclusivity on the sales of the BP and BAN during the term of the contract. Pricing strategies shall be reviewed and agreed by both parties. This contracting approach is the same as the current set-up and the Agency will share some of its historic sales data and trends at its supplier event and in the tender documentation. We expect to award the contract in April 2022 and agree a contract with mobilisation in September 2022 to facilitate sufficient lead time for implementation and the publication of the BP 2024 in August 2023. We will be holding a supplier engagement event on 18th January 2022 13.30 - 15.30 via a MS Teams video conference to discuss with potential suppliers the requirement and service expectations, and further considerations for the future contract. We will also allow time for questions and answers. If interested in attending or if you have a question you would specifically like to be addressed in session, please email purchasing@mhra.gov.uk with your details (quoting BP Event).",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "79970000",
            "description": "Publishing services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "E14 4PU"
                    },
                    {
                        "region": "England",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "procurementMethodDetails": "Other -",
        "communication": {
            "futureNoticeDate": "2022-01-24T23:59:59Z"
        },
        "contractPeriod": {
            "startDate": "2022-09-01T00:00:00+01:00",
            "endDate": "2027-08-31T23:59:59+01:00"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        }
    },
    "parties": [
        {
            "id": "GB-CFS-192825",
            "name": "Medicines and Healthcare products Regulatory Agency",
            "identifier": {
                "legalName": "Medicines and Healthcare products Regulatory Agency"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Alison Finn",
                "email": "alison.finn@nibsc.org",
                "telephone": "07770234628"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-192825",
        "name": "Medicines and Healthcare products Regulatory Agency"
    }
}